Nov 17, 2020 | AIMS-2-TRIALS News
Understanding individual differences in early brain development can help predict long-term outcomes in children who are later found to be autistic. Because children’s brains develop rapidly, measurements need to focus on factors that are relatively stable, rather than...
Sep 8, 2020 | AIMS-2-TRIALS News
New research led by King’s College London has provided insight into why exposure to inflammation caused by a viral infection during pregnancy may increase the likelihood of altered brain development later on in childhood. Many thanks to KCL for their permission to...
Sep 8, 2020 | AIMS-2-TRIALS News
The AIMS-2-TRIALS consortium has received feedback (qualification advice) from the European Medicines Agency (EMA) on the further exploration of EEG (electroencephalography) as a potential ‘biomarker’ in autism research. Finding measures to identify subgroups of...
Jul 20, 2020 | Newsletter1 Research News
Return to newsletter The COVID-19 pandemic will affect the running of many of our research projects during the next few months but AIMS-2-TRIALS will continue to work towards its existing goals, perhaps with a minor extension to its final end date. Many universities...
Jul 19, 2020 | Newsletter1 Research News
Autistic people have quicker and shorter eye movements and a narrower area of focus than non-autistic people, according to a new study by AIMS-2-TRIALS partners from Goethe University in Frankfurt. Previous research has shown that autistic people tend to look less at...
